Alexion Pharmaceuticals, Inc. (ALXN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)

An SI Board Since October 1997

Posts	SubjectMarks	Bans	Symbol
824	29	0	ALXN

Emcee: Larry Liebman	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
99	<i>Is it really wrong to be in love with a biotech investment?</i> U	nigel bates	-	9/25/2000
98	In trying to learn what we get for $41m in stock, here are the only 2 Press Re	keokalani'nui	-	9/25/2000
97	Excellent story with best glossary I've seen yet. I've reproduced here.	Ian@SI	-	9/25/2000
96	ALXN Acquires Prolifaron Establishing Premier Antibody and Development Platform	Jongmans	-	9/25/2000
95	Alexion Pharmaceuticals Inc. (ALXN) Chief Scientific Officer and Senior Vice Pre	Jim Oravetz	-	9/19/2000
94	Referenced CNBC interview available at nasdaq.com after entering ticker and sear	Ian@SI	-	9/8/2000
93	FDA Grants ALEXION Fast Track Status for C5 Inhibitor in Bypass Patients.... bi	Jongmans	-	9/7/2000
92	local coverage:NEW HAVEN — Genetically modified pig cells can spur spinal cord r	Jim Oravetz	-	8/31/2000
91	Yale and Alexion Report Advance in Spinal Cord Repair-Study Published in Nature	Jongmans	-	8/29/2000
90	Alexion completed rheumatoid arthritis patient enrollment for a Phase II efficac	Jim Oravetz	-	8/24/2000
89	... a brief extract from that story. <i>The last time Franklin M. Berger	Ian@SI	-	7/26/2000
88	Interesting Article in WSJ (Interactive) on Top Biotechnology Analysts with thei	Jongmans	-	7/26/2000
87	The article linked here mentions the ALXN xeno transplant program: Message 1408	Biomaven	-	7/21/2000
86	There's an article in the latest BMJ on inflammation in heart disease. In pa	Biomaven	-	7/21/2000
85	Institutional Holdings in ALXN now higher than ever. Apparently above 90% now.	Jongmans	-	6/11/2000
84	the Kaufman Fund now holds 5.19% of ALXN (784,000 shares) according to an Edgar	Ian@SI	-	6/8/2000
83	Third Quarter and nine Months Financial Results biz.yahoo.com martin	Jongmans	-	6/8/2000
82	ALXN on the Net June 8th Presenting at Informed Investors .com information:	Jongmans	-	6/7/2000
81	ALXN seems very attractive at this pricelevel martin	Jongmans	-	5/30/2000
80	Peter, Thanks for retrieving the Abstract and especially for the URL to the JC	Ian@SI	-	5/19/2000
79	The underlying article with a ALXN co-author: <i>Predominant role for C5	Biomaven	-	5/19/2000
78	Nice 2 minute audio clip describing some of the significance of ALXN's scie	Ian@SI	-	5/18/2000
77	Alexion Pharmaceuticals (ALXN) 38 1/8: Announced the publication of a scientifi	Jim Oravetz	-	5/15/2000
76	Summary of some of the key recent events for ALXN toward the end of this extrac	Ian@SI	-	5/10/2000
75	Jim, DJN has also picked up the story. May appear in today's WSJ as well.	Ian@SI	-	5/4/2000

Go to reply# or date (mm/dd/yy):